Melatonin-loaded MSCs-derived exosomes as therapeutic carriers to alleviate levodopa-induced dyskinesia in Parkinson's disease
{{output}}
Parkinson's disease (PD) causes dopaminergic neuron damage in substantia nigra, with levodopa-induced dyskinesia (LID) as a side effect of long-term treatment with levodopa. Exosomes (Exo) from mesenchymal stem cells (MSC) are getting attention as nanosized c... ...
